Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEURRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 16.7 | -4.8 | 11.6 | 5.0 | |
+/-Cat | - | 1.4 | 3.5 | 0.0 | -0.7 | |
+/-B’mrk | - | -0.9 | -0.2 | -1.6 | -1.3 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 26/04/2024 | GBX 719.80 | |
Day Change | 1.34% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 133 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BKSBGT50 | |
Fund Size (Mil) 26/04/2024 | EUR 95.11 | |
Share Class Size (Mil) 26/04/2024 | EUR 95.11 | |
Ongoing Charge 03/04/2024 | 0.25% |
Investment Objective: Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEUR |
The Sub-Fund aims to achieve long-term capital growth from a portfolio primarily made up of equity securities of companies in Europe. The Sub-Fund aims to achieve its investment objective by actively investing in a portfolio primarily made up of equity securities of companies domiciled, or exercising the predominant part of their economic activity, in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Hiten Savani 18/05/2020 | ||
Daniel Swift 18/05/2020 | ||
Inception Date 18/05/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEUR | 26/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.06 |
ASML Holding NV | Technology | 3.65 |
Shell PLC | Energy | 3.09 |
TotalEnergies SE | Energy | 2.59 |
AstraZeneca PLC | Healthcare | 2.55 |
Increase Decrease New since last portfolio | ||
Fidelity Sustainable Research Enhanced Europe Equity UCITS ETF EUR Acc (GBP) | FEUR |